Back to search

Article

Thiol drugs decrease SARS-CoV-2 lung injury <i>in vivo</i> and disrupt SARS-CoV-2 spike complex binding to ACE2 <i>in vitro</i>

2020-12-08

Abstract excerpt

Neutrophil-induced oxidative stress is a mechanism of lung injury in COVID-19, and drugs with a functional thiol group (“thiol drugs”), especially cysteamine, have anti-oxidant and anti-inflammatory properties that could limit this injury. Thiol drugs may also alter the redox status of the cysteine-rich SARS-CoV-2 spike glycoprotein (SARS-2-S) and thereby disrupt ACE2 binding. Using ACE2 binding assay, reporter vi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8a3c2dc2-e948-56ae-b303-ab61ecdb6570
DOI
10.1101/2020.12.08.415505
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Thiol drugs decrease SARS-CoV-2 lung injury <i>in vivo</i> and disrupt SARS-CoV-2 spike complex binding to ACE2 <i>in vitro</i>DOI 10.1101/2020.12.08.415505
Select a neighboring publication to make it the new centre.